Alkermes plc. ALKS revenue by segment, product and geography
In its fiscal year ending 2025-12-31, Alkermes plc. reported revenue across 7 products and services; the largest, Product, was $1.18B (+9.3% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Product$1.18Bshare n/a+9.3% yoy
- Vivitrol$468Mshare n/a+2.3% yoy
- Aristada And Aristada Initio$370Mshare n/a+6.9% yoy
- LYBALVI$347Mshare n/a+23.8% yoy
- Manufactured Product And Royalty$291Mshare n/a-38.6% yoy
- Royalty$245Mshare n/a-30.8% yoy
- Manufacturing Revenue$46Mshare n/a-61.5% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- United States$1.37B93.0%-2.7% yoy
- Foreign Country Excluding Specified Country$102M6.9%-30.0% yoy
- Ireland$754K0.1%-41.7% yoy
Members sum to the consolidated $1.48B for this period.
- Product$412Mshare n/ano prior
- Vivitrol$124Mshare n/ano prior
- Aristada And Aristada Initio$96.7Mshare n/ano prior
- LUMRYZ$96.6Mshare n/ano prior
- LYBALVI$94Mshare n/ano prior
- Manufactured Product And Royalty$84.3Mshare n/ano prior
- +2 more members in the filing
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.